跳至主要内容
临床试验/ISRCTN76316509
ISRCTN76316509已完成不适用

Comparative evaluation of immunogenicity of monovalent type 1 oral poliovirus vaccine (mOPV1) versus trivalent OPV (tOPV): a randomised double-blind trial set in Egypt

World Health Organization (WHO) (Switzerland)0 个研究点目标入组 600 人开始时间: 2006年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Infants born healthy (greater than or equal to 2.75 kg, apgar score greater than or equal to 9 at five minutes) at the study site(s) (large maternity hospitals)
  • 2. Residing within a relatively short and easily accessible distance (less than 30 km) in the same governorate as the study site
  • 3. Not planning to travel away during entire the study period (birth to two months)

排除标准

  • 1. High-risk newborns will be excluded
  • 2. Newborns requiring hospitalisation
  • 3. Birth weight below 2.75 kg
  • 4. Apgar score less than 9 at five minutes
  • 5. Residence greater than 30 km from study site (or residing in another governorate)
  • 6. Family is planning to be absent during the 60-day study period
  • 7. A diagnosis or suspicion of immunodeficiency disorder (either in the participant or in a member of the immediate family) will render the newborn ineligible for the study

研究者

发起方
World Health Organization (WHO) (Switzerland)

相似试验

已完成
不适用
Comparative evaluation of Immunogenicity of monovalent type 1 Oral Poliovirus Vaccine (mOPV1) and monovalent type 3 Oral Poliovirus Vaccine (mOPV3) versus trivalent Oral Poliovirus Vaccine (tOPV): a randomised double-blind controlled trial in South AfricaPoliomyelitisInfections and Infestations
ISRCTN18107202World Health Organization (WHO) (Switzerland)800
已完成
不适用
Comparative evaluation of immunogenicity of Monovalent Type 1 Oral Poliovirus Vaccine (mOPV1) versus trivalent OPV (tOPV): a randomised double-blind trial set in India (Panacea Biotec Ltd mOPV1 study)PolioInfections and Infestations
ISRCTN80143849Panacea Biotec Ltd (India)600
尚未招募
4 期
Comparative evaluation of immunogenicity of various schedules and delivery options to provide fractional Dose Inactivated Poliovirus Vaccine in routine immunizatio
CTRI/2017/02/007793Panacea Biotec Ltd800
撤回
4 期
A comparison of the immune response to two different oral polio vaccine regimes in PakistaPoliomyelitisPublic Health - EpidemiologyInfection - Other infectious diseasesOral and Gastrointestinal - Normal oral and gastrointestinal development and function
ACTRN12611000824965Department of Paediatrics and Child Health, Aga Khan University800
招募中
4 期
Comparing immune response to oral polio vaccine administered at short intervals with vaccine administered at standard intervals in healthy newborns in PakistapoliomyelitisInfection - Other infectious diseasesPublic Health - Other public health
ACTRN12612000276853WHO800
Comparative evaluation of immunogenicity of... | 临床试验